Clinical Trial Update: Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

View source ↗

Summary

An ongoing study using passive sensors to identify digital biomarkers and assess the effects of oral nicotinamide riboside in Alzheimer's disease and related de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Mclean Hospital | Conditions: Alzheimer Disease, Dementia Alzheimers | Status: RECRUITING